drugset / Trial / NCT00452335
Safety and Efficacy of Lubiprostone in Pediatric Patients With Constipation
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The primary purpose of this study is to evaluate the safety and efficacy of lubiprostone in a pediatric population with constipation, including the pharmacokinetics of lubiprostone, in a subset of patients.
Timeline
- Start
- 2007-01
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lubiprostone | Small molecule | 12 ug | — |
| Subject | Lubiprostone | Small molecule | 24 ug | — |